NASDAQ · AKLI
Healthcare · Medical - Healthcare Information Services
$0.43
Up+$0.00 (+0.25%)
Updated Oct 8, 2026, 4:56 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · AKLI
1M range · 0 trading sessions · Daily adjusted prices
AKLI does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning AKLI.
Company
Market Activity
Research & News
AKLI research
Company profile and research snapshot.
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 11, 2023 | Credit Suisse | Outperform | — |
| Jan 25, 2023 | Morgan Stanley | Equal-Weight | — |
| Dec 28, 2022 | Morgan Stanley | Equal-Weight | — |
| Nov 18, 2022 | B of A Securities | Neutral | — |
| Nov 15, 2022 | Credit Suisse | Outperform | — |
No generated briefing is available yet.
Zacks Investment Research · Dec 21, 2023
Akili, Inc. (AKLI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks Investment Research · Nov 6, 2023
Hims & Hers Health, Inc. (HIMS) delivered earnings and revenue surprises of -33.33% and 3.03%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Benzinga · Jan 25, 2023
Analysts have provided the following ratings for Akili (NASDAQ:AKLI) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 1 3 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 0 1 1 0 0 In the last 3 months, 4 analysts have offered 12-month price targets for Akili. The company has an average price target of $2.88 with a high of $4.50 and a low of $2.00. Below is a summary of how these 4 analysts rated Akili over ...Full story available on Benzinga.com
PennyStocks · Jan 5, 2023
Hot penny stocks with news to watch this week. The post 5 Hot Penny Stocks Exploding After News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AKLI.
No results
No recent SID articles mention AKLI.
